Target intelligence / Profile preview

Hemoglobin subunit mu (HBM)

Target
HBM
Molecular classification
Other (globin family; hemoprotein; non-canonical globin; not an enzyme, receptor, nor transporter)
01

Overview

Hemoglobin subunit mu is a member of the human globin gene family, specifically within the alpha globin gene cluster on chromosome 16. It encodes a 141-amino-acid polypeptide similar to delta globins found in non-mammalian species such as birds and reptiles. Although its mRNA is expressed at moderate levels, the actual protein has not been convincingly detected via mass spectrometry or other proteomic techniques[1][2]. Its evolutionary origin, previously as a pseudogene, and uncertain protein expression suggest that it may have little—if any—physiological role in humans apart from being a genomic remnant of evolutionary divergence within the globin superfamily[2][6]. Diseases associated with this locus include alpha-thalassemia, likely due to cluster-level effects rather than direct involvement of HBM as an expressed protein[1]. Summary of main issues: - Status as a protein-coding gene is disputed; formerly annotated as a pseudogene. - No confirmed detection of the encoded protein. - Not validated as a therapeutic target, biomarker, or disease gene in humans. - Not recognized as a major globin component, unlike alpha or beta globin subunits.

Other names
HBAP2Hemoglobin mu chainMu-globinAlpha globin pseudogene 2Hemoglobin, mu
02

Biological functions

Iron ion bindingOxygen bindingPossible involvement in erythroid lineage regulation
03

Disease associations

Alpha-thalassemia (association based on its location and similarity to other globin genes; no direct evidence linking HBM function to disease)

Beyond the preview

Go deeper on Hemoglobin subunit mu (HBM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit mu (HBM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call